Skip to content

VIELA BIO, INC.

CIK 0001734517

← back to feed
Revenue (TTM)
$11.65M
−61.2% YoY FY Mar 2021
Net Income (TTM)
−$165.69M
−1,202.3% YoY FY Mar 2021
EPS Diluted (TTM)
—
FY Mar 2021
Gross Margin
—
FY Mar 2021
Operating Margin
-1,451.1%
FY Mar 2021
Net Margin
-1,422.0%
FY Mar 2021
Free Cash Flow (TTM)
−$107.04M
FY Mar 2021
Cash
$130.07M
FY Mar 2021
Total Debt
—
FY Mar 2021
Shares Outstanding
54.95M sh
FY Mar 2021

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings